LeadCare II Blood Lead Test Kit Control Test Inaccuracy Recall
The LeadCare II Blood Lead Test Kit may generate artificially low control test results, causing blood lead levels to be underestimated in patient samples. Kits were distributed worldwide.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: This FDA Class I medical device recall involves control test inaccuracy that can lead to underestimation of blood lead levels. No deaths or injuries are reported, but the Class I designation indicates reasonable probability of serious adverse health consequences.
Plain-English summary
Magellan Diagnostics, Inc. has recalled 387,281 LeadCare II Blood Lead Test Kits (Catalog Number 70-6762) due to control test inaccuracy. Control tests may generate artificially low results, which can cause blood lead levels in patient samples to be underestimated.
The affected kits were distributed worldwide, including throughout the United States and Puerto Rico, as well as Canada, Vietnam, India, Italy, Peru, New Zealand, Australia, Hong Kong, and the Philippines. Multiple lot numbers from 2013M through 7114M with expiration dates between April 2022 and December 2022 are affected.
If you have used or have in possession a LeadCare II kit with a matching lot number, contact Magellan Diagnostics for recall instructions. Healthcare providers and laboratories should review results from affected kits for any potential impact on patient care decisions.
The recalled product
- Product
- LeadCare II Blood Lead Test Kit Catalog Number 70-6762
- Manufacturer
- Magellan Diagnostics, Inc.
- Hazard
- test-inaccuracy
- false-negative
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (20)
- Lot Numbers/Expiration Date: 2013M - 22APR22
- 2014M - 29APR22
- 2015M - 12MAY22
- 2016M - 19MAY22
- 2017M - 10JUN22
- 1st expansion 6/21/2021: 2101M - 28JUL22
- 2103M - 18AUG22
- 2105M - 11SEP22
- 2106M - 21JAN22
- 2107M - 30SEP22
- 2nd expansion 8/30/2021
- 2012M Sublots: -08
- -09
- -10
- -11
- -12
- -13
- -14 - 08APR22
- 2018M - 06JUN22
- 2102M - 30SEP21
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- SevereMEDLINE Medical Procedure Kits Containing Bupivacaine Recalled Due to Drug Ineffectiveness
FDA (Devices) · 2026-07-29
- HighSafeOp Patient Interface Neuromonitoring Device Recalled Due to Software Issue
FDA (Devices) · 2026-07-29
- HighPenumbra System RED 68 Reperfusion Catheter Recall Due to Fracture Risk
FDA (Devices) · 2026-07-29
- ModerateFARASTAR Ablation Generator EU Medical Device Recall for Labeling Discrepancy
FDA (Devices) · 2026-07-29
- High